Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients

Nutrition and Cancer

Volumn 31, Issue 2, 1998, Pages 101-105

  McMillan, Donald C ^a   Scott, Hazel R ^b   Watson, Walter S ^b   Preston, Tom ^c   Milroy, Robert ^b   McArdle, Colin S ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; POTASSIUM;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; CANCER PATIENT; CLINICAL ARTICLE; CORRELATION FUNCTION; DIGESTIVE SYSTEM CANCER; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; LUNG CANCER; MALE; SKINFOLD;

EID: 0031782577     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589809514687     Document Type: Article

References (23)

1. Moore, FD: Energy and maintenance of the body cell mass. J Parent Enteral Nutr 4, 228-260, 1980.
2. Warnold, I, Lundholm, K, and Schersten, T: Energy balance and body composition in cancer patients. Cancer Res 38, 1801-1807, 1978.
3. Cohn, SH, Gartenhaus, W, Sawitsky, A, Rai, K, Zanzi, I, et al.: Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium and water. Metabolism 30, 222-229, 1981.
4. Moley, JF, Aamodt, R, Rumble, MS, Kaye, W, and Norton, JA: Body cell mass in cancer-bearing and anorexic patients. J Parent Enteral Nutr 11, 219-222, 1987.
5. Macfie, J, and Burkinshaw, L: Body composition in malignant disease. Metabolism 36, 290-294, 1987.
6. Preston, T, Fearon, KCH, Robertson, I, East, BW, and Calman, KC: Tissue loss during severe wasting in lung cancer patients. In In Vivo Body Composition Studies, edited by KJ Ellis, S Yasumura, and WD Morgan. London: Inst Phys Sci Med, 1987, pp 60-69.
7. McMillan, DC, Preston, T, Watson, WS, Simpson, JM, Fearon, KCH, et al.: The relationship between weight loss, reduction of body cell mass and the inflammatory response in cancer patients. Br J Surg 81, 1011-1014, 1994.
8. Watson, WS: Total body potassium measurement: the effect of fallout from Chernobyl. Clin Phys Physiol Meas 8, 337-341, 1987.
9. Doumas, BT, Watson, W, and Biggs, HG: Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta 31, 87-96, 1971.
10. Boddy, K, King, PC, Hume, R, and Weyers, E: The relation of total body potassium to height, weight and age in normal adults. J Clin Pathol 25, 512-517, 1972.
11. Finn, PJ, Plank, LD, Clark, MA, Connelly, AB, and Hill, GL: Progressive cellular dehydration and proteolysis in critically ill patients. Lancet 347, 654-656, 1996.
12. 15N]glycine. Nutrition 10, 232-240, 1994.
13. Preston, T, Fearon, KCH, McMillan, DC, Winstanley, FP, Slater, C, et al.: Effect of ibuprofen on the acute phase response and protein metabolism in patients with cancer and weight loss. Br J Surg 82, 229-234, 1995.
14. Falconer, JS, Fearon, KCH, Plester, CE, Ross, JA, and Carter, DC: Cytokines, the acute phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219, 325-331, 1994.
15. Wigmore, SJ, Plester, CE, Ross, JA, and Fearon, KCH: Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84, 196-197, 1997.
16. Scott, HR, McMillan, DC, Crilly, A, McArdle, CS, and Milroy, R: The relationship between weight loss and interleukin-6 in non-small cell lung cancer. Br J Cancer 73, 1560-1562, 1996.
17. Wigmore, SJ, Plester, CE, Richardson, RA, and Fearon, KCH: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75, 106-109, 1997.
18. Fearon, KCH, McMillan, DC, Preston, T, Winstanley, P, Cruickshank, AM, et al.: Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 213, 26-31, 1991.
19. Fearon, KCH, Falconer, JS, Slater, C, McMillan, DC, Ross, JA, et al.: Albumin synthesis rates are not decreased in hypoalbuminaemic cachectic cancer patients with an ongoing acute phase protein response. Ann Surg 227, 249-254, 1998.
20. McMillan, DC, O'Gorman, P, Fearon, KCH, and McArdle, CS: A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients. Br J Cancer 76, 788-790, 1997.
21. Van Gameren, MM, Willemse, PHB, Mulder, NH, Limburg, PC, Groen, HJM, et al.: Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 84, 1434-1441, 1994.
22. Roubenoff, R, Roubenoff, RA, Cannon, JG, Kehayias, JJ, Zhuang, H, et al: Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93, 2379-2386, 1994.
23. Wigmore, SJ, Ross, JA, Falconer, JS, Plester, CE, Tisdale, MJ, et al.: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12, s27-s30, 1996.